These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 19430335)
1. Angiogenesis in the kidney: a new therapeutic target? Lerman LO; Chade AR Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):160-5. PubMed ID: 19430335 [TBL] [Abstract][Full Text] [Related]
2. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis. Chade AR Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R783-90. PubMed ID: 21307362 [TBL] [Abstract][Full Text] [Related]
3. Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? Chade AR; Stewart N J Am Soc Hypertens; 2013; 7(2):180-90. PubMed ID: 23428409 [TBL] [Abstract][Full Text] [Related]
4. VEGF therapy for the kidney: emerging strategies. Guise E; Chade AR Am J Physiol Renal Physiol; 2018 Oct; 315(4):F747-F751. PubMed ID: 29442546 [TBL] [Abstract][Full Text] [Related]
5. Role of renal microcirculation in experimental renovascular disease. Iliescu R; Fernandez SR; Kelsen S; Maric C; Chade AR Nephrol Dial Transplant; 2010 Apr; 25(4):1079-87. PubMed ID: 19934087 [TBL] [Abstract][Full Text] [Related]
6. Renal vascular structure and rarefaction. Chade AR Compr Physiol; 2013 Apr; 3(2):817-31. PubMed ID: 23720331 [TBL] [Abstract][Full Text] [Related]
7. Restoring the renal microvasculature to treat chronic kidney disease. Long DA; Norman JT; Fine LG Nat Rev Nephrol; 2012 Feb; 8(4):244-50. PubMed ID: 22310952 [TBL] [Abstract][Full Text] [Related]
9. Renal microvascular assembly and repair: power and promise of molecular definition. Takahashi T; Huynh-Do U; Daniel TO Kidney Int; 1998 Apr; 53(4):826-35. PubMed ID: 9551388 [TBL] [Abstract][Full Text] [Related]
10. VEGF: Potential therapy for renal regeneration. Chade AR F1000 Med Rep; 2012; 4():1. PubMed ID: 22238513 [TBL] [Abstract][Full Text] [Related]
18. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. Kang DH; Joly AH; Oh SW; Hugo C; Kerjaschki D; Gordon KL; Mazzali M; Jefferson JA; Hughes J; Madsen KM; Schreiner GF; Johnson RJ J Am Soc Nephrol; 2001 Jul; 12(7):1434-1447. PubMed ID: 11423572 [TBL] [Abstract][Full Text] [Related]
19. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia. Chade AR; Krier JD; Textor SC; Lerman A; Lerman LO J Am Soc Nephrol; 2006 Dec; 17(12):3394-403. PubMed ID: 17082239 [TBL] [Abstract][Full Text] [Related]
20. Renal microvascular disease determines the responses to revascularization in experimental renovascular disease. Chade AR; Kelsen S Circ Cardiovasc Interv; 2010 Aug; 3(4):376-83. PubMed ID: 20587789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]